GH Rabbit

Growth Hormone Rabbit Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to GH Rabbit (Growth Hormone Receptor/Binding Protein in Rabbits)

The term "GH Rabbit" refers to either the Growth Hormone Receptor (GHR) or the Growth Hormone Binding Protein (GHBP) derived from rabbits. These proteins play critical roles in growth regulation and cellular signaling. GHR is a transmembrane receptor that binds growth hormone (GH), while GHBP is a soluble form generated through proteolysis of the extracellular domain (ECD) of GHR. Below is a detailed analysis of their structure, function, and research findings.

Growth Hormone Receptor (GHR)

The rabbit GHR is a 249-amino-acid polypeptide chain produced via recombinant expression in E. coli. Key properties include:

PropertySpecificationSource
Molecular Weight28 kDa (non-glycosylated)
Purity>98% (SDS-PAGE analysis)
StabilityLyophilized: -18°C; Reconstituted: 4°C (2–7 days)
Binding AffinityBinds human GH with linear range 1–16 ng/mL

The recombinant GHR (His-tagged) migrates as 36–50 kDa under reducing conditions due to glycosylation .

Growth Hormone Binding Protein (GHBP)

GHBP is generated through proteolytic cleavage of GHR’s ECD. Studies in rabbit cell models reveal:

  • Cleavage Site: Located 8 residues from the membrane in the proximal ECD stem region .

  • Regulation:

    • Temperature-Dependent: GHBP release is reduced at low temperatures (e.g., 4°C) .

    • Protease Inhibition: Benzamidine (10 mM) reduces GHBP secretion but also decreases cellular GHR levels .

Polymorphisms in GHR and Growth Traits

Genetic studies in rabbits identify polymorphisms linked to growth and carcass traits:

GenePolymorphismTrait AssociationStrainSource
GHc.-78C>TGrowth weight (Belgian Grey, NZW × BGG)Belgian Grey, NZW × BGG
GHRc.106G>CMeat weight (intermediate part), dressing percentageTermond White

Haplotype Effects:

  • TT/CC: Higher hind meat weight in Belgian Giant Grey rabbits.

  • CC/CC: Lowest intermediate/hind meat weight in crossbred rabbits .

Proteolysis Mechanism and Interspecies Differences

Comparative studies between rabbit and mouse GHRs highlight:

  • Cleavage Site Sensitivity: Rabbit GHR’s cleavage site (SPFT) is more susceptible to proteolysis than mouse GHR’s (NILEA) .

  • Mutagenesis Impact: Replacing rabbit cleavage residues with mouse residues (e.g., rbGHR-NILEA/SPFT) reduces proteolysis efficiency .

Cell Model Systems

Chinese hamster ovary (CHO) cells transfected with rabbit GHR cDNA serve as models to study GHBP shedding:

  • Kinetics: Linear GHBP release observed over 4 hours .

  • Protein Synthesis: Cycloheximide (20 μg/mL) reduces GHBP secretion, with a half-life of ~50 minutes .

Agricultural and Biomedical Relevance

  • Breeding Programs: Polymorphisms in GH and GHR genes are validated as markers for growth and carcass traits in rabbit strains .

  • Therapeutic Targets: Insights into GHR proteolysis inform strategies for modulating GH signaling in growth disorders .

Table 1: Growth Trait Correlations with GHR Polymorphisms

TraitGenetic Correlation (P-value)StrainAge (Weeks)Source
Chest GirthPositive (BL, LBW)New Zealand White6–30
Body WeightSignificant (P < 0.05)Hylamax6, 14, 18
Tail LengthModerate (P < 0.05)Dutch22, 26

Table 2: Biochemical Properties of Recombinant GHR

ParameterValueSource
Expression SystemE. coli
Reconstitution0.4% NaHCO₃, pH 10
Storage-18°C (lyophilized), 4°C (reconstituted)

Product Specs

Introduction
Growth hormone (GH) is part of the somatotropin/prolactin hormone family, essential for regulating growth. Located on chromosome 17, the GH gene resides within the growth hormone locus alongside four related genes, all sharing the same transcriptional orientation. This arrangement likely arose from gene duplication events. These five genes exhibit high sequence similarity. The production of diverse isoforms from these genes is facilitated by alternative splicing, potentially enabling specialized functions. Although expressed in the pituitary gland, this particular family member, unlike the other four genes in the growth hormone locus, is not found in placental tissue. Mutations or deletions in this gene can result in growth hormone deficiency, leading to short stature.
Description
Recombinant Rabbit Growth Hormone, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 190 amino acids. It has a molecular weight of 21.774 kDa. The purification of GH is achieved using proprietary chromatographic methods.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The protein was lyophilized from a 1 mg/mL solution containing 0.0045 mM NaHCO3.
Solubility
To reconstitute the lyophilized Rabbit Growth Hormone, it is recommended to dissolve it in sterile 18 MΩ-cm H2O to a concentration of at least 100 µg/mL. This solution can then be further diluted in other aqueous solutions.
Stability
Lyophilized Rabbit Growth Hormone remains stable at room temperature for up to 3 weeks. However, it is recommended to store it desiccated at -18°C. Once reconstituted, Rabbit GH should be stored at 4°C for 2-7 days. For long-term storage, freeze at -18°C. To enhance stability during long-term storage, adding a carrier protein (0.1% HSA or BSA) is advisable. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 97.0% using the following methods: (a) Size Exclusion Chromatography-High Performance Liquid Chromatography (SEC-HPLC) analysis. (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.
Synonyms
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, Growth hormone 1, Somatotropin.
Source
Escherichia Coli.

Q&A

What are the primary characteristics of Growth Hormone Receptors (GHR) in rabbit brain tissues?

Central Growth Hormone Receptors (GHR) in rabbits have been identified in both hypothalamic and extra-hypothalamic brain tissues. Research demonstrates that plasma membranes of the rabbit brain contain specific saturable high-affinity, low-capacity binding sites for 125I-labelled GH . These receptors show similar binding characteristics to peripheral GH receptors but exhibit tissue-specific distribution patterns. When conducting receptor binding studies in rabbit brain tissue, it is methodologically important to use fresh or properly preserved tissue samples to maintain receptor integrity, employ appropriate radioligand concentrations (typically in the nanomolar range), and include specific controls for non-specific binding. Researchers should establish saturation curves and Scatchard analyses to determine binding affinities and receptor densities, while also considering the potential influence of endogenous GH levels on receptor expression.

How does the expression of GHR mRNA in rabbit brain compare to liver GHR expression?

RNA extracted from hypothalamic and extra-hypothalamic tissues of rabbit brains contains mRNA that hybridizes with a cDNA probe for the rabbit liver GHR . The brain GHR transcript appears to be of a similar size to the major GHR mRNA found in rabbit liver, suggesting conservation of receptor structure across tissues. Importantly, the expression of these GHR mRNA moieties is age-related, with higher levels observed in adult animals compared to neonatal rabbits . This developmental pattern indicates potential regulatory mechanisms affecting GHR expression throughout maturation. For researchers investigating developmental differences in GHR expression, it is essential to properly age-match experimental groups, control for potential sex-based differences, and employ quantitative PCR techniques with appropriate reference genes for accurate comparison between brain regions and peripheral tissues.

What are the fundamental physiological connections between Growth Hormone-Releasing Factor (GRF) and sleep regulation in rabbits?

Research has established that Growth Hormone-Releasing Factor (GRF) influences sleep patterns in rabbits, promoting both non-rapid eye movement sleep (NREMS) and rapid eye movement sleep (REMS) . This connection provides a potential mechanistic link between GH secretion and sleep regulation. Studies demonstrate that intracerebroventricular injection of GRF in rabbits increases NREMS and REMS while enhancing EEG slow-wave activity . The sleep-promoting effects of GRF follow a dose-dependent pattern, with NREMS increasing in post-injection hour 1 after low doses while showing more prolonged effects at higher doses . These findings suggest that GRF may serve as a key link between GH secretion and sleep regulatory mechanisms in rabbits.

What are the optimal methods for investigating GRF effects on sleep architecture in rabbit models?

When designing experiments to study GRF influences on sleep in rabbits, researchers should employ a comprehensive methodological approach. Based on established protocols, artificial cerebrospinal fluid or various doses of GRF (typically human GRF-[1-40], at concentrations of 0.01, 0.1, and 1 nmol/kg) should be administered intracerebroventricularly . Sleep parameters to monitor include electroencephalogram (EEG), brain temperature, and motor activity, with recordings extending at least 6-24 hours post-injection to capture both immediate and delayed effects .

The experimental design should include appropriate controls and counterbalanced administration schedules to account for potential circadian effects. For comprehensive sleep architecture analysis, researchers should quantify:

  • NREMS duration and latency

  • REMS duration and latency

  • EEG slow-wave activity power spectra

  • Sleep bout frequency and duration

  • Brain temperature fluctuations correlated with sleep states

Statistical analysis should incorporate repeated measures approaches to account for time-dependent effects and individual variability in response to GRF administration.

How can genomic-assisted selection (GAS) techniques be applied to GH-related research in rabbits?

Genomic-assisted selection (GAS) represents an advanced approach for investigating GH-related traits in rabbits. GAS encompasses several techniques including genomic selection (GS), marker-assisted selection (MAS), and genome-wide association studies (GWAS) that utilize genomic data to understand and enhance rabbit breeding and physiological traits . When applying these techniques to GH research, researchers should:

  • Establish reference populations with comprehensive phenotypic and genotypic data

  • Employ appropriate SNP density panels specific to rabbit genomics

  • Develop statistical models to estimate SNP effects on GH-related traits

  • Calculate genomic estimated breeding values (GEBV) based on genotypic data

Recent advances have identified large numbers of high-quality SNPs across the rabbit genome, with imputation accuracy exceeding 98% using multi-trait genomic selection models . For example, one study identified 20,125,019 high-quality SNPs with imputation accuracy greater than 98%, providing a robust foundation for GH-related genomic studies .

What methodological approaches are most effective for investigating the relationship between GH receptors and age-dependent expression in rabbits?

To effectively investigate age-dependent GH receptor expression in rabbits, researchers should implement a multi-faceted methodological approach that includes:

  • Tissue-specific sampling from multiple brain regions (hypothalamic and extra-hypothalamic) and peripheral tissues across clearly defined developmental stages

  • RNA extraction with high-quality preservation methods to prevent degradation

  • Quantitative RT-PCR with validated reference genes appropriate for rabbit tissues

  • Hybridization studies using specific cDNA probes for rabbit GHR

  • Protein expression analysis via Western blotting and immunohistochemistry to correlate mRNA with functional receptor expression

Research has demonstrated that GHR expression is age-related, with higher levels in adult animals compared to neonatal rabbits . This ontogenetic pattern suggests developmental regulation of GH sensitivity. When designing age-comparison studies, it is critical to control for potential confounding variables including sex, nutritional status, and circadian timing of sample collection, as these factors may independently influence GH receptor expression.

How should researchers interpret conflicting data between central and peripheral GH receptor expression patterns in rabbits?

When confronted with discrepancies between central and peripheral GH receptor expression patterns in rabbits, researchers should implement a systematic analytical approach:

  • Evaluate methodological differences that might contribute to conflicting results (sample preparation, assay sensitivity, detection methods)

  • Consider tissue-specific post-transcriptional modifications that might affect receptor functionality despite similar mRNA expression

  • Investigate potential regulatory factors that might differentially impact central versus peripheral GH signaling

  • Assess developmental time points, as age-related differences in GHR expression have been observed between adult and neonatal animals

  • Employ multiple complementary techniques (binding assays, mRNA quantification, protein expression, functional studies) to provide converging evidence

Researchers should also consider potential differences in receptor isoforms, as alternative splicing may generate tissue-specific receptor variants with distinct functions. Integration of findings across methodologies and experimental conditions is essential for resolving apparent contradictions in the literature.

What statistical approaches are most appropriate for analyzing dose-dependent effects of GRF on rabbit sleep parameters?

The analysis of dose-dependent GRF effects on rabbit sleep requires sophisticated statistical approaches to account for time-dependence, individual variability, and non-linear dose-response relationships. Based on published methodologies, researchers should consider:

  • Repeated measures ANOVA to assess treatment effects across time points

  • Mixed-effects modeling to account for individual subject variability

  • Non-linear regression approaches for dose-response curve determination

  • Time-series analysis for evaluating temporal patterns in EEG and sleep stages

  • Principal component analysis for integrating multiple sleep parameters into composite variables

When analyzing experimental data, it is important to note that GRF effects on NREMS may increase in post-injection hour 1 after low doses while showing more prolonged effects at higher doses . Similarly, REMS increases have been observed in response to low and middle doses of GRF in post-injection hour 1 in rats and in hour 2 after each dose in rabbits . These temporal and dose-dependent patterns require careful statistical consideration to properly characterize the relationship between GRF and sleep regulation.

How can researchers effectively apply genomic selection (GS) in GH-related rabbit research?

Genomic selection (GS) represents a powerful approach for investigating GH-related traits in rabbits by utilizing genomic-estimated breeding values (GEBV) derived from genome-wide markers. To effectively implement GS in GH research, researchers should:

  • Establish comprehensive reference populations with detailed phenotypic data on GH-related traits

  • Employ appropriate genotyping strategies, considering that genotype imputation can identify SNP density across the rabbit genome to improve cost-efficiency

  • Develop statistical models to estimate SNP effects on GH-related phenotypes

  • Calculate GEBVs based on genotypic data to predict genetic traits even without reliable phenotypic data

Recent research has demonstrated successful application of these approaches in rabbit genomics. For example, studies have achieved 3.84% genomic coverage with 18,577,154 high-quality SNPs imputed with 98% accuracy . Similarly, another study produced 20,125,019 high-quality SNPs with imputation accuracy exceeding 98% using multi-trait GS models .

What genomic techniques can be used to identify functional genes associated with GH response in rabbits?

To identify functional genes associated with GH response in rabbits, researchers can employ several advanced genomic techniques:

  • Genome-wide association studies (GWAS) to identify SNPs associated with GH-related traits

  • Genotyping-by-sequencing methods to discover relevant genetic markers

  • Restriction-site associated DNA sequencing for SNP identification across the rabbit genome

  • Low-coverage whole genome sequencing with sophisticated imputation algorithms

These approaches have yielded significant discoveries in rabbit genomics. For instance, researchers have identified 32,144 SNPs through genotyping-by-sequencing, revealing genes associated with important rabbit traits . Similarly, GWAS has identified 189 SNPs with 20 candidate genes associated with feed efficiency and growth performance , both of which may relate to GH function. For GH-specific research, these techniques can be adapted to focus on genes involved in GH signaling pathways, receptor expression, and downstream effectors.

Genomic TechniqueSNPs IdentifiedAccuracyApplications in GH Research
Low-coverage WGS + imputation18,577,15498%GH receptor variants, signaling pathway genes
Multi-trait GS model20,125,019>98%GH-related growth and metabolic traits
Genotyping-by-sequencing32,144Not specifiedGH-responsive genes and regulatory elements
GWAS189Not specifiedFeed efficiency and growth performance genes
Restriction-site associated DNA seq91,456Not specifiedGenome-wide SNP identification

What considerations are important when designing experiments to investigate the relationship between GH and sleep in rabbits?

When designing experiments to investigate GH-sleep relationships in rabbits, researchers should consider several critical factors:

  • Experimental timing: Since GH secretion and sleep exhibit circadian patterns, the timing of interventions and measurements is crucial. Studies should control for time-of-day effects and synchronize procedures with the natural activity cycle of rabbits.

  • Route of administration: For GRF studies, intracerebroventricular injection has been established as effective, with dosages typically ranging from 0.01 to 1 nmol/kg .

  • Measurement parameters: Comprehensive assessment should include EEG, brain temperature, motor activity, and potentially direct measurement of GH levels through serial blood sampling .

  • Duration of monitoring: Effects on NREMS and REMS may appear in different time windows post-intervention, with some effects occurring in the first hour and others emerging later. Monitoring should extend at least 6-24 hours .

  • Individual variability: Statistical power calculations should account for individual differences in response to GH-related interventions.

  • Genetic background: When using genomic approaches, the genetic lineage of experimental animals should be carefully documented, as different rabbit strains may exhibit varying GH sensitivity and sleep architecture.

How do findings from rabbit GH research compare to those from other experimental models?

Comparing GH research across species provides valuable insights into conserved mechanisms and species-specific adaptations. Rabbit models offer unique advantages in certain research contexts:

  • GRF effects on sleep: Studies demonstrate that GRF promotes both NREMS and REMS and increases EEG slow-wave activity in both rats and rabbits , suggesting conservation of basic GH-sleep regulatory mechanisms across rodents and lagomorphs.

  • GH receptor distribution: While central GH receptors have been identified in rabbit and chicken brains , species differences exist in receptor density, affinity, and regional distribution that may reflect evolutionary adaptations.

  • Developmental patterns: Age-related changes in GHR expression have been observed in rabbits , which may parallel developmental patterns in other species but with specific temporal profiles.

When translating findings between rabbits and other models, researchers should consider physiological differences in GH pulsatility, receptor structure, and downstream signaling pathways. Comparative studies should employ standardized methodologies to minimize technique-related variability when assessing cross-species differences.

What are the most significant challenges in applying genomic techniques to GH research in rabbits?

Despite the potential of genomic approaches in rabbit GH research, several significant challenges must be addressed:

  • Cost considerations: The efficiency of genomic selection for identifying genetic marker information and breeding values is compromised by high genotyping costs, though genotype imputation methods have improved cost-efficiency .

  • Reference population requirements: Establishing adequate reference populations with both phenotypic and genotypic data remains challenging, particularly for specialized GH-related traits that may require invasive measurement.

  • Analytical complexity: The integration of multi-trait genomic prediction models requires sophisticated statistical approaches, particularly when dealing with traits of varying heritability.

  • Functional validation: While genomic approaches can identify potential candidate genes associated with GH-related traits, functional validation of these associations requires additional experimental approaches.

  • Integration across platforms: Combining data from different genomic technologies (e.g., SNP arrays, whole-genome sequencing, RNA-seq) presents bioinformatic challenges that must be addressed through standardized analysis pipelines.

Researchers have begun addressing these challenges through advanced approaches such as genotype imputation to identify SNP density across the rabbit genome, which has significantly improved the cost-efficiency of genomic selection in rabbits .

Product Science Overview

Introduction

Growth hormone, also known as somatotropin, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in animals and humans. Recombinant growth hormone is produced using recombinant DNA technology, which allows for the production of growth hormone identical to that naturally produced by the pituitary gland. In this article, we will explore the background, synthesis, and applications of recombinant growth hormone specifically in rabbits.

Synthesis and Production

Recombinant growth hormone is synthesized using genetic engineering techniques. The gene encoding rabbit growth hormone is inserted into a suitable expression vector, which is then introduced into a host organism, typically bacteria or yeast. The host organism expresses the growth hormone gene, producing the recombinant protein. The recombinant growth hormone is then purified from the host cells through various chromatographic techniques.

In some cases, transgenic animals, such as rabbits, are used to produce recombinant growth hormone. For example, the recombinant growth hormone can be expressed in the milk of transgenic rabbit females, allowing for easy collection and purification . This method ensures high yields of the recombinant protein and reduces the risk of contamination with other proteins.

Applications

Recombinant growth hormone has several applications in both research and medicine. In research, it is used to study the effects of growth hormone on various physiological processes, such as growth, metabolism, and aging. It is also used to develop and test new growth hormone agonists and antagonists.

In medicine, recombinant growth hormone is used to treat growth hormone deficiencies in humans and animals. It is administered to individuals with growth hormone deficiency to stimulate growth and improve overall health. In veterinary medicine, recombinant growth hormone is used to promote growth and improve the health of livestock and pets.

Pharmacodynamics and Biomarkers

The pharmacodynamics of recombinant growth hormone in rabbits have been studied extensively. One of the key biomarkers used to monitor the bioactivity of growth hormone is insulin-like growth factor I (IGF-I). IGF-I levels in the serum are indicative of growth hormone activity and can be used to assess the efficacy of growth hormone treatments .

Studies have shown that the IGF-I response to recombinant growth hormone in rabbits closely mimics the pharmacodynamics seen in humans . This makes rabbits a suitable model for testing human growth hormone agonists and antagonists. Additionally, factors such as sex, age, and genetic background significantly influence IGF-I levels in rabbits .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.